AVXL 241220 8.00C (AVXL241220C8000) Stock Options, News & Quotes

US OptionsDetailed Quotes

AVXL241220C8000

Watchlist

0.85
-0.45-34.62%

15min DelayTrading Dec 19 10:38 ET

0.85High0.71Low

Intraday

5D
Daily

News

Earnings Preview: AVXL to Report Financial Results Pre-market on December 23
Moomoo NewsDec 17 20:00 ET
Anavex Life Sciences Corp. to Announce Fiscal Year 2024 Financial Results on December 23, 2024
Quiver QuantitativeDec 16 07:41 ET
Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer's Disease Data at J.P. Morgan 2025 Healthcare Conference
GlobeNewswireDec 9 07:30 ET
Earnings Week Ahead: ORCL, GME, ADBE, COST, AVGO, M and More
Seeking AlphaDec 8 08:01 ET
Anavex Life Sciences Down Over 13%, On Track for Largest Percent Decrease Since January -- Data Talk
Dow JonesDec 5 15:12 ET
Anavex Life Sciences to Present at the 7th Annual Evercore ISI HealthCONx Conference 2024
GlobeNewswireDec 2 07:30 ET

Comments

Rhiox

Dec 16 08:43

$Anavex Life Sciences (AVXL.US)$ crossing over mid Bollinger band on day chart , possible to see 9. + soon

Rhiox

Dec 13 15:48

$Anavex Life Sciences (AVXL.US)$
$Sunshine Biopharma (SBFM.US)$
$Rumble (RUM.US)$
Got a few superbouncy balls this evening.
making me dizzy 🤣

Rhiox

Dec 12 08:26

$Anavex Life Sciences (AVXL.US)$ 👀

Jaguar8

Dec 9 06:55

NEWS

$Anavex Life Sciences (AVXL.US)$
Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference
Anavex Life Sciences (Nasdaq: AVXL) announced it will present new long-term data from the Phase IIb/III ATTENTION-AD Open-Label-Extension (OLE) trial for blarcamesine in early Alzheimer's disease at the J.P. Morgan 2025 Healthcare Conference. The presentation will showcase data from up to 144 weeks of continuous treatm...

Rhiox

Nov 26 07:18

$Anavex Life Sciences (AVXL.US)$ nice